The picture theory of seven pathways associated with COVID-19 in the real world

Author:

Lee Jong hoon1,Sergi Consolato2,Kast Richard E.3,Kanwar Badar A.4,Altschuler Eric L.5,Bourbeau Jean6,Oh Sangsuk7,Sohn Mun-Gi8,Lee Kun Ho9,Coleman Michael D.10

Affiliation:

1. Seoul National University College of Medicine

2. University of Ottawa

3. IIAIGC Study Center

4. Haider Associates

5. Metropolitan Hospital New York

6. McGill University Health Centre

7. Ewha Womans University

8. KyungHee University College of Life Science

9. Chosun University

10. Aston University

Abstract

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces immune-mediated diseases. Interactions between the host and virus govern induction, resulting in multiorgan impacts In 2021, as normal life was challenging during the pandemic era, we analyzed SCI journals according to L. Wittgenstein's Tractatus Logi-co-Philosophicus. The pathophysiology of coronavirus disease 2019 (COVID-19) involves 1) the angiotensin-converting enzyme (ACE2) and Toll-like receptor (TLR) pathways starting with eight, from 2022.01.14., and rediscovered with nineteen, to 2024.01.10., 2) the neuropilin (NRP) pathway with seven and successful with twenty four, 3) the sterile alpha motif (SAM) and histidine-aspartate domain (HD)-containing protein 1 (SAMHD1) tetramerization pathway with two and successful with thirteen, 4) inflammasome activation pathways with five and successful with thirteen, 5) the cytosolic DNA sensor cyclic-GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) (cGAS–STING) signaling pathway with six and successful with eleven, 6) the spike protein pathway with fourteen and successful with twenty three, 7) the immunological memory engram pathway with thirteen and successful with eighteen, and 8) the excess acetylcholine pathway with three and successful with nine. We reconfirmed that COVID-19 involved seven (1–7) pathways and a new pathway involving excess acetylcholine. Therefore, it is necessary to therapeutically alleviate and block the pathological course harmoniously with modulating innate lymphoid cells (ILCs) if subsequent diverse SARS-CoV-2 variants are encountered in the future.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3